Combination treatment with oHSV and Trametinib enhanced virus replication mediated by down-regulation of STAT1 and PKR expression or phosphorylation in BRAF V600E-mutated tumor cells as well as BRAF wt/KRAS-mutated tumor cells (3). Here, EIF2AK2 is linked to neoplasm.